Your CMO for Sterile Injectables
More Content From Your CMO for Sterile Injectables
-
Considerations and Options for Prefilled Syringes
Learn the options available for prefilled syringes and some considerations for developing and manufacturing the product.White Papers / Tech Papers Released on 03.16.2021
-
Seasonal Vaccine Manufacturing
There are three areas to evaluate when selecting an outsourcing partner for seasonal vaccine manufacturing.White Papers / Tech Papers Released on 02.12.2021
-
Leak Rate Testing for Freeze Dryers: A Scientific Approach
Assurance of the vacuum integrity of freezedryers used for the manufacture of sterile pharmaceutical products is essential for GMP operations.White Papers / Tech Papers Released on 03.08.2019
-
Pharmaceutical Development for ADCs: Not as Simple as ABC
...White Papers / Tech Papers Released on 03.08.2019
-
BIOSIMILARS: Global Terminology, Strategy & Pathways
Download the Global Terminology, Strategy & Pathways PosterPosters Released on 03.08.2019
-
Enhanced Delivery Options for Injectables
Download the Enhanced Delivery Options Poster.Posters Released on 03.08.2019
-
Considerations for Development of Lyophilized Biosimilar
This whitepaper discusses considerations for development of a lyophilized biosimilar, as well as a biosimilar case study.White Papers / Tech Papers Released on 11.01.2018
-
Baxter's BioPharma Solutions Business Recognized with ViE Award for Fifth Time
...News Releases Released on 07.06.2018
-
Capabilities Brochure - The Promise of Science Maximized
...Literature / Brochures Released on 07.06.2018
-
Manufacturing of Cytotoxic and Non-Cytotoxic Drugs in a Multiproduct Facility
When different drug products are produced in shared facilities, the potential for cross contamination is always a concern.White Papers / Tech Papers Released on 07.06.2018
-
The Promise of Science: Baxter’s Lyophilization Center of Excellence
...Literature / Brochures Released on 07.01.2018
